ALUX Acquires Additional Shares of Subsidiary ER for 7.96B KRW, Boosting Stake to 100% – Premium Payment for Weak Finances Raises Long-Term Profitability Concerns
ALUX decided to acquire 730,131 new shares of its subsidiary ER Co., Ltd. for 7.96B KRW (17.5% of equity), increasing its stake to 100%, with the acquisition date postponed from June 1 to July 31, 2026 due to court review delays.
The transaction is a restructuring: ALUX will contribute its 85.66% stake in ER VINA Vietnam to ER in exchange for new shares of ER.
The purpose is to enhance manufacturing decision-making and operational efficiency, simplifying the group structure.
However, ER's financials as of 2025 show total assets of 5.13B KRW, liabilities of 4.47B, equity of 0.67B, and a net loss of 1.05B, indicating a very weak financial position with negative equity trend.
The acquisition price of 7.96B KRW is approximately 12 times ER's net assets (0.67B), reflecting a high premium and potential impairment risk in the future.
[AI Comprehensive Analysis]While the transaction aims to improve governance efficiency, it effectively assumes losses by injecting high-value assets into a financially weak subsidiary; shareholders should focus on the possibility of long-term profitability deterioration rather than short-term dilution.
KOSDAQ Filing Information
Filing: [Correction of Description] Decision on Acquisition of Stocks and Equity Securities of Other Corporations